Skip to main content

Table 1 Clinical characteristics of AGCT in stage IC

From: Is adjuvant chemotherapy beneficial for patients with FIGO stage IC adult granulosa cell tumor of the ovary?

  All patients NACG ACG p
N = 60 N = 28 (%) N = 32 (%)
Age (median) 41.0 41.5 40.5 0.410
Tumor size (cm) 8 7 8.4 0.523
Serum Ca125(U / ml) 15.5 14.4 16.4 0.751
Menopause     0.744
Yes 14 (23.3) 6 (21.4) 8 (25.0)  
No 46 (76.7) 22 (78.6) 24 (75.0)  
FIGO stage (%)     0.944
IC1 34 (56.7) 16 (57.1) 18 (56.2)  
IC2-IC3 26 (43.3) 12 (42.9) 14 (43.8)  
Surgical procedure     0.605
Fertility surgery 30 (50.0) 15 (53.6) 15 (46.9)  
Radical surgery 30 (50.0) 13 (46.4) 17 (53.1)  
Staging operation     0.102
Yes 26 (43.3) 9 (32.1) 17 (53.1)  
No 34 (56.7) 19 (67.9) 15 (46.9)  
Lymphadenectomy     0.245
Yes 24 (40.0) 9 (32.1) 15 (46.9)  
No 36 (60.0) 19 (67.9) 17 (53.1)  
First operation at clinical     0.696
Our clinical 37 (61.7) 18 (64.3) 19 (59.4)  
Outer 23 (38.3) 10 (35.7) 13 (40.6)  
  1. AGCT: adult granulosa cell tumor; ACG: adjuvant chemotherapy group; NACG: no adjuvant chemotherapy group